FDA Signs off on New Version of Abortion Pill Mifepristone
FRIDAY, Oct. 3, 2025 (HealthDay News) — A new low-cost version of the abortion pill mifepristone just received federal approval and it’s already stirring political controversy. The U.S. Food and Drug Administration (FDA) recently granted approval to Evita Solutions for its generic version of mifepristone, a medication used to endContinue Reading